Metraipolis › archive › dc_bfdbdd112d0e

The impact of anti-phosphatidylserine/prothrombin antibodies on pregnancy outcomes in patients with unexplained recurrent implantation failure: a… — Europe PMC PMID:41646861

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41646861
DOI: 10.3389/fimmu.2026.1731905
License (as archived): solo-consultazione
Archived: 2026-11-06T15:50:51.348Z
SHA-256 of the archived text: 21c6b6df7b2b3419d2dc3370ee91593844b1ac2086f34c383c793c3e506f9438
Stable URL of this page: https://metraipolis.com/documento/dc_bfdbdd112d0e

How to cite

The impact of anti-phosphatidylserine/prothrombin antibodies on pregnancy outcomes in patients with unexplained recurrent implantation failure: a… — Europe PMC PMID:41646861 — Europe PMC (en), https://europepmc.org/article/MED/41646861 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bfdbdd112d0e (Metraipolis archive dc_bfdbdd112d0e, sha256 21c6b6df7b2b3419d2dc3370ee91593844b1ac2086f34c383c793c3e506f9438)

BibTeX

@misc{dcbfdbdd112d0e,
  title = {The impact of anti-phosphatidylserine/prothrombin antibodies on pregnancy outcomes in patients with unexplained recurrent implantation failure: a… — Europe PMC PMID:41646861},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41646861},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bfdbdd112d0e; sha256 21c6b6df7b2b3419d2dc3370ee91593844b1ac2086f34c383c793c3e506f9438},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41646861. Agents can read the archived copy with the MCP tool read_document.